Droxidopa for neurogenic orthostatic hypotension: A randomized, placebo-controlled, phase 3 trial

OBJECTIVE: To determine whether droxidopa, an oral norepinephrine precursor, improves symptomatic neurogenic orthostatic hypotension (nOH). METHODS: Patients with symptomatic nOH due to Parkinson disease, multiple system atrophy, pure autonomic failure, or nondiabetic autonomic neuropathy underwent...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Kaufmann, Horacio, Freeman, Roy, Biaggioni, Italo, Low, Phillip, Pedder, Simon, Hewitt, L. Arthur, Mauney, Joe, Feirtag, Michael, Mathias, Christopher J.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4115605/
https://ncbi.nlm.nih.gov/pubmed/24944260
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000000615
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados